Melanoma and Skin Cancer Trials (MASC Trials) brings together the world’s leading researchers and institutions to develop, conduct and publish ground-breaking, investigator-initiated clinical trials that are changing how we diagnose and treat melanoma and skin cancer. Our vision is to improve the lives of melanoma and skin cancer patients and their families through conducting the highest-quality collaborative research, including clinical trials. This collaborative approach sits at the heart of everything we do and enables genuinely life-changing results that were long thought impossible. With an outstanding record of developing and leading ground-breaking multicentre, international trials since 1999, MASC Trials relies on government funding and the generosity of our community to deliver best practice treatments for ‘Australia’s cancer’. MASC Trials Ltd is registered as a charity with the Australian Charity and Not-for Profits Commission. ABN 70 626 908 512.